Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Bullboard Posts
Post by mineplanner08on Oct 17, 2015 10:44am
217 Views
Post# 24201137

A Few Things

A Few Things
  • The $155M year-end guidance is identical to the previous $200M minus the three un-closed LOI deals.  I wouldn't be surprised if no more deals went through this year as it likely makes more sense to buy back shares in the $0.40s rather than add new companies at 3-6x EBITDA.
  • The organic growth of 15-20% only accounts for one of the five components of the updated growth strategy.  See page 15 of the investor presentation.  It would make sense that some of the others could be considered organic but they appear to be categorizing differenty.
  • Donville is on BNN Monday evening.  His fund holds PHM, NHC, CXR, VRX and other recent losers in the space.
Bullboard Posts